Explore the MASH Market, projected to reach $7.64B by 2031 with a 21.8% CAGR. Insights into treatment options, regional prevalence, and key players. https://www.datamintelligence.com/research-report/metabolic-dysfunction-associated-steatohepatitis-mash-market